THC BIOMED INTL LTD.Acquisition Agreement • April 24th, 2018
Contract Type FiledApril 24th, 2018Vancouver, British Columbia (April 24, 2018) THC BioMed Intl Ltd. (CSE: THC), ("THC" or the "Company") THC executed a definitive agreement, further to entering into a Letter of Intent previously announced April 4, 2018, with Burleigh Heads Cannabis Pty Ltd, an Australian licensed importer and wholesaler of medical cannabis, (the “BHC”) and its shareholders for the acquisition of 51% of that company. Upon completion, THC will become the majority shareholder and parent company of BHC and will also have the right to appoint two out of three directors to the Board of the target company. While it is the intention that BHC will list as a public company in Australia, there are no assurances that the target company will ever apply to or become a public company.
THC BIOMED INTL LTD.Acquisition Agreement • April 24th, 2018
Contract Type FiledApril 24th, 2018Vancouver, British Columbia (April 24, 2018) THC BioMed Intl Ltd. (CSE: THC), ("THC" or the "Company") THC executed a definitive agreement, further to entering into a Letter of Intent previously announced April 4, 2018, with Burleigh Heads Cannabis Pty Ltd, an Australian licensed importer and wholesaler of medical cannabis, (the “BHC”) and its shareholders for the acquisition of 51% of that company. Upon completion, THC will become the majority shareholder and parent company of BHC and will also have the right to appoint two out of three directors to the Board of the target company. While it is the intention that BHC will list as a public company in Australia, there are no assurances that the target company will ever apply to or become a public company.